Items where authors include "Park-Simon, T-W"

Article

Dennis, J, Tyrer, JP, Walker, LC et al. (121 more authors) (2022) Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology, 5. 65. ISSN 2399-3642

Ahearn, TU, Zhang, H, Michailidou, K et al. (202 more authors) (2022) Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research, 24 (1). 2.

Park, HA, Neumeyer, S, Michailidou, K et al. (274 more authors) (2021) Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer, 125. pp. 1135-1145. ISSN 0007-0920

Morra, A, Escala-Garcia, M, Beesley, J et al. (175 more authors) (2021) Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research, 23 (1). 86.

Baxter, JS, Johnson, N, Tomczyk, K et al. (180 more authors) (2021) Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. The American Journal of Human Genetics, 108 (7). pp. 1190-1203. ISSN 0002-9297

Johnson, N, Maguire, S, Morra, A et al. (145 more authors) (2021) CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4). pp. 842-854. ISSN 0007-0920

Kramer, I, Hooning, MJ, Mavaddat, N et al. (264 more authors) (2020) Breast cancer polygenic risk score and contralateral breast cancer risk. The American Journal of Human Genetics, 107 (5). pp. 837-848. ISSN 0002-9297

Zhang, H, Ahearn, TU, Lecarpentier, J et al. (269 more authors) (2020) Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature Genetics, 52 (6). pp. 572-581. ISSN 1061-4036

Fachal, L, Aschard, H, Beesley, J et al. (338 more authors) (2020) Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics, 52 (1). pp. 56-73. ISSN 1061-4036

Oza, AM, Cook, AD, Pfisterer, J et al. (21 more authors) (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncology, 16 (8). pp. 928-936. ISSN 1470-2045